"Unlocking the Secrets of CDMO Pricing: A Game-Changer for Life Sciences
As a seasoned professional in the life sciences industry, I’ve seen firsthand the impact of Contract Development and Manufacturing Organization (CDMO) pricing on the bottom l…

Exciting times in the world of generic drugs!
As we navigate the ever-changing landscape of pharmaceuticals, I wanted to share some key takeaways from a recent article on Mergers and Acquisitions in generic drug development.
Opportunities:

Increased e…

"Biosimilars are no longer just a cost-containment strategy, but a key player in population health management initiatives. By leveraging biosimilars, healthcare systems can improve patient outcomes, reduce healthcare disparities, and enhance overa…

"Unlocking the Power of Biopharma Intelligence: A Paradigm Shift
As the biopharma landscape continues to evolve, the way we access and analyze data is no longer sufficient. Traditional analyst-driven approaches are giving way to direct access to r…

"Just spent the morning digging into the impact of biosimilars on the generic drug industry in Europe.
Key takeaways:

Biosimilars are projected to reach €53.6 billion in sales by 2028, up from €1.3 billion in 2020.
The European market is expecte…

"Just spent the day digging into the world of post-ANDA drug development patent hacks and I’ve got to say, it’s a wild ride.
The team at DrugPatentWatch has done an incredible job breaking down the key strategies for winning in this space. From l…

"Just spent the morning digging into the global generic drug market trends, opportunities, and challenges.
Key takeaways:
The global generic drug market is projected to reach $1.24 trillion by 2028, growing at a CAGR of 9.5% from 2023 to 2028.
Th…

"Unlocking Efficiency in Generic Drug Development
As the pharmaceutical industry continues to evolve, digital transformation is playing a crucial role in streamlining generic drug development. At Drug Patent Watch, we’ve seen firsthand the benefit…